Member access

4-Traders Homepage  >  Shares  >  SIX SWISS EXCHANGE AG  >  Roche Holding Ltd.       CH0012032048

 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( CHF)
Sales 2015 47 465 M
EBIT 2015 16 894 M
Net income 2015 11 125 M
Debt 2015 8 855 M
Yield 2015 3,02%
Sales 2016 49 538 M
EBIT 2016 18 035 M
Net income 2016 12 201 M
Debt 2016 6 087 M
Yield 2016 3,20%
PER 2015 20,57
PER 2016 18,91
EV / Sales 2015 5,17x
EV / Sales 2016 4,90x
Capitalization 236 576 M
More Financials
Company
Roche Holding AG is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics.As a large biotech company, Roche has truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.It is also a leader in in-vitro... 
Sector
Pharmaceuticals
Calendar
04/22 | 01:00amSales and Revenue Release
More about the company
Surperformance© ratings of Roche Holding Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on ROCHE HOLDING LTD.
10:49aDJRoche Holding 1Q 2015 -- Forecast
04/15DJCorrection to 'Study Sparks Debate on Accuracy of Genome Tests' Article
04/15DJStudy Sparks Debate on Accuracy of Genome Tests for Cancer Patients
04/12DJHow the Hottest Biotech Sprouted in Iowa
04/08DJROCHE : European Regulators Approved Roche's Avastin for Cervical Cancer Treatme..
04/02 ROCHE BEARER SHARE : Ariosa's Harmony™ Prenatal Test shown to be superior ..
03/22 Currency hedging takes on new importance for global stock funds
03/19 ROCHE : Sigma-Aldrich : Announces Exclusive Distribution Agreement with Roche
More news
Sector news : Pharmaceuticals - NEC
11:03p TEVA PHARMACEUTICAL : BRIEF: Mylan says it is not interested in merger with Isra..
08:16p TEVA PHARMACEUTICAL : Mylan discounts speculation of a possible takeover by Teva
05:54p VALEANT PHARMACEUTICALS INTL : senior executives scored US$123 million compensat..
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF